Alpha 2.0
Login Register
» Articles » PMID: 36039520

Case Report: Up-front Allogeneic Stem Cell Transplantation in a Patient with the VEXAS Syndrome

Overview
Journal Br J Haematol
Specialty Hematology
Date 2022 Aug 30
PMID 36039520
Authors
Nathalie van Leeuwen-Kerkhoff
Moniek A de Witte
Marloes W Heijstek
Helen L Leavis
Affiliations
Soon will be listed here.
Citing Articles

VEXAS Syndrome: A Comprehensive Review of Current Therapeutic Strategies and Emerging Treatments.

Alqatari S, Alqunais A, Alali S, Alharbi M, Hasan M, Al Shubbar M J Clin Med. 2024; 13(22).

PMID: 39598114 PMC: 11594742. DOI: 10.3390/jcm13226970.

Allogenic haematopoietic stem cell transplantation in VEXAS: A review of 33 patients.

Ali S, Gurnari C Clin Rheumatol. 2024; 43(11):3565-3575.

PMID: 39347920 PMC: 11489273. DOI: 10.1007/s10067-024-07160-7.

Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome.

Dias A, Groarke E, Hickstein D, Patel B Ann Hematol. 2024; 103(11):4427-4436.

PMID: 39168911 PMC: 11535077. DOI: 10.1007/s00277-024-05942-2.

Clinical Manifestations in Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome: A Narrative Review.

Padureanu V, Marinas C, Bobirca A, Padureanu R, Patrascu S, Dascalu A Cureus. 2024; 16(1):e53041.

PMID: 38410307 PMC: 10895688. DOI: 10.7759/cureus.53041.

Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT.

Gurnari C, Koster L, Baaij L, Heiblig M, Yakoub-Agha I, Collin M Blood Adv. 2024; 8(6):1444-1448.

PMID: 38330178 PMC: 10955646. DOI: 10.1182/bloodadvances.2023012478.